2024-10-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.91% |
4.23% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.86% |
-0.32% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
6.61% |
-3.48% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
7.49% |
9.26% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
7.38% |
7.64% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
6.62% |
-3.37% |
2024-10-15 |
CDXS
Codexis, Inc.
|
Buy |
6.81% |
-0.59% |
2024-10-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
6.64% |
-3.09% |
2024-10-16 |
VREX
Varex Imaging Corporation
|
Buy |
6.39% |
0% |
2024-10-18 |
NKTR
Nektar Therapeutics
|
Buy |
6.39% |
0% |
2024-10-18 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
6.39% |
0% |
2024-10-18 |
AXSM
Axsome Therapeutics, Inc.
|
Buy |
6.39% |
0% |
2024-10-18 |
CUTR
Cutera, Inc.
|
Sell |
-3.34% |
12% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.8% |
-0.31% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.72% |
0.35% |
2024-10-07 |
BHVN
Biohaven Ltd.
|
Sell |
-3.95% |
-0.33% |
2024-10-17 |
The percentage of cash held in the portfolio is:
33.95%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
AXSM |
Buy
All
|
-7.81% |
RDNT |
Sell
All
|
-3.2% |
Assets Rebalanced
None
2024-10-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.88% |
5.63% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
7.13% |
5.52% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
6.52% |
-3.15% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
7.43% |
10.41% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
7.34% |
8.99% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
6.6% |
-1.95% |
2024-10-15 |
RDNT
RadNet, Inc.
|
Buy |
6.71% |
-0.34% |
2024-10-15 |
CDXS
Codexis, Inc.
|
Buy |
6.99% |
3.83% |
2024-10-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
6.88% |
2.27% |
2024-10-16 |
CUTR
Cutera, Inc.
|
Sell |
-3.38% |
9.25% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.73% |
0% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.61% |
1.5% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-3.81% |
-3.9% |
2024-10-07 |
BHVN
Biohaven Ltd.
|
Sell |
-3.87% |
0% |
2024-10-17 |
The percentage of cash held in the portfolio is:
55.91%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ORMP |
Buy
All
|
-1.67% |
Assets Rebalanced
None
2024-10-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.78% |
3.05% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
7.09% |
3.9% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
6.72% |
-1.16% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
6.82% |
0.33% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
6.98% |
2.69% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
6.78% |
-0.33% |
2024-10-15 |
RDNT
RadNet, Inc.
|
Buy |
6.81% |
0.2% |
2024-10-15 |
CDXS
Codexis, Inc.
|
Buy |
6.8% |
0% |
2024-10-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
6.8% |
0% |
2024-10-16 |
CUTR
Cutera, Inc.
|
Sell |
-3.46% |
8% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.58% |
4.98% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-3.7% |
1.67% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.55% |
4.11% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-3.7% |
0.18% |
2024-10-07 |
The percentage of cash held in the portfolio is:
56.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.66% |
0.7% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.89% |
0.32% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
6.78% |
-0.83% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
6.84% |
0% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
6.84% |
0% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
6.84% |
0% |
2024-10-15 |
RDNT
RadNet, Inc.
|
Buy |
6.84% |
0% |
2024-10-15 |
CUTR
Cutera, Inc.
|
Sell |
-3.58% |
5.33% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.6% |
4.98% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-3.77% |
0.42% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.44% |
7.61% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-3.68% |
1.35% |
2024-10-07 |
The percentage of cash held in the portfolio is:
70.38%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.64% |
0% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.87% |
-0.32% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
6.86% |
0% |
2024-10-14 |
CUTR
Cutera, Inc.
|
Sell |
-3.85% |
-1.33% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.66% |
3.74% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-3.78% |
0.42% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.4% |
8.99% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-3.78% |
-1.12% |
2024-10-07 |
The percentage of cash held in the portfolio is:
98.1%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.54% |
-1.17% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.74% |
-1.95% |
2024-10-07 |
CUTR
Cutera, Inc.
|
Sell |
-3.69% |
2.67% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.47% |
8.41% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-3.81% |
-0.42% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.41% |
8.5% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-3.58% |
4.05% |
2024-10-07 |
The percentage of cash held in the portfolio is:
104.67%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BCRX |
Sell
All
|
-6.07% |
Assets Rebalanced
None
2024-10-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.69% |
0.94% |
2024-10-03 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
6.88% |
0% |
2024-10-07 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.88% |
0% |
2024-10-07 |
CUTR
Cutera, Inc.
|
Sell |
-3.79% |
0% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.81% |
-0.31% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-3.73% |
1.67% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.73% |
0% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-3.73% |
0% |
2024-10-07 |
The percentage of cash held in the portfolio is:
98.34%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CERS |
Buy
All
|
19.43% |
Assets Rebalanced
None
2024-10-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.64% |
0% |
2024-10-03 |
CERS
Cerus Corporation
|
Sell |
-3.42% |
19.91% |
2024-09-05 |
CUTR
Cutera, Inc.
|
Sell |
-3.8% |
0% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.8% |
0% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-3.8% |
0% |
2024-10-03 |
The percentage of cash held in the portfolio is:
108.17%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CERS
Cerus Corporation
|
Sell |
-3.54% |
17.06% |
2024-09-05 |
The percentage of cash held in the portfolio is:
103.54%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
LMAT |
Buy
All
|
-3% |
AVXL |
Buy
All
|
3.4% |
PODD |
Sell
All
|
13.51% |
Assets Rebalanced
None
2024-09-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
10.49% |
15.17% |
2024-08-29 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-4.03% |
-1.4% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.84% |
3.57% |
2024-08-29 |
CERS
Cerus Corporation
|
Sell |
-3.6% |
15.64% |
2024-09-05 |
The percentage of cash held in the portfolio is:
100.97%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
STAA |
Buy
All
|
-4.63% |
Assets Rebalanced
None
2024-09-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
10.56% |
16.82% |
2024-08-29 |
STAA
STAAR Surgical Company
|
Sell |
-3.86% |
4.11% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.96% |
-0.25% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.66% |
7.31% |
2024-08-29 |
CERS
Cerus Corporation
|
Sell |
-3.55% |
16.11% |
2024-09-05 |
The percentage of cash held in the portfolio is:
104.46%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
AADI |
Sell
All
|
8.57% |
NVCR |
Sell
All
|
-11.63% |
Assets Rebalanced
None
2024-09-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.86% |
8% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
10.59% |
16.92% |
2024-08-29 |
NVCR
NovoCure Limited
|
Buy |
7.21% |
-8.98% |
2024-09-06 |
STAA
STAAR Surgical Company
|
Sell |
-4.02% |
0.25% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-4.05% |
-2.35% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.74% |
5.44% |
2024-08-29 |
CERS
Cerus Corporation
|
Sell |
-3.62% |
14.69% |
2024-09-05 |
The percentage of cash held in the portfolio is:
90.76%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MYGN |
Sell
All
|
-1.56% |
Assets Rebalanced
None
2024-09-24 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.9% |
9.14% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
10.54% |
16.9% |
2024-08-29 |
NVCR
NovoCure Limited
|
Buy |
7.21% |
-8.42% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.47% |
-0.15% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-3.76% |
6.21% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-4.04% |
-2.66% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.67% |
6.63% |
2024-08-29 |
CERS
Cerus Corporation
|
Sell |
-3.56% |
15.64% |
2024-09-05 |
The percentage of cash held in the portfolio is:
82.91%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ESPR |
Sell
All
|
-10.93% |
Assets Rebalanced
None
2024-09-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.92% |
10.29% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
10.35% |
15.73% |
2024-08-29 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.11% |
-8.2% |
2024-09-02 |
NVCR
NovoCure Limited
|
Buy |
7.56% |
-3.32% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.61% |
2.48% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-3.74% |
6.12% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.95% |
-1.03% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.75% |
4.08% |
2024-08-29 |
CERS
Cerus Corporation
|
Sell |
-3.57% |
14.69% |
2024-09-05 |
The percentage of cash held in the portfolio is:
74.44%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
AGEN |
Sell
All
|
6.76% |
Assets Rebalanced
None
2024-09-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AGEN
Agenus Inc.
|
Buy |
6.59% |
11.15% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.74% |
7.43% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
10.24% |
14.42% |
2024-08-29 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.5% |
-3.83% |
2024-09-02 |
NVCR
NovoCure Limited
|
Buy |
7.78% |
-0.5% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.69% |
3.45% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-3.86% |
3.06% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.95% |
-1.08% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.79% |
3.06% |
2024-08-29 |
CERS
Cerus Corporation
|
Sell |
-4.09% |
2.37% |
2024-09-05 |
The percentage of cash held in the portfolio is:
68.14%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MGNX |
Sell
All
|
-2.28% |
APLS |
Sell
All
|
-8.89% |
TVTX |
Sell
All
|
48.65% |
Assets Rebalanced
None
2024-09-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.8% |
-3.75% |
2024-08-22 |
AGEN
Agenus Inc.
|
Buy |
6.22% |
3.11% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.72% |
5.14% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
10.15% |
11.4% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.28% |
3.13% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.55% |
-4.92% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
8.84% |
27.5% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
7.6% |
-4.54% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.37% |
-2.56% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-3.79% |
6.36% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.87% |
2.57% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.47% |
12.76% |
2024-08-29 |
CERS
Cerus Corporation
|
Sell |
-4.14% |
2.84% |
2024-09-05 |
The percentage of cash held in the portfolio is:
44.75%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VREX |
Buy
All
|
2.22% |
Assets Rebalanced
None
2024-09-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.92% |
-1.69% |
2024-08-22 |
AGEN
Agenus Inc.
|
Buy |
6.01% |
-0.18% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.49% |
1.71% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
10.08% |
10.8% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.11% |
1.42% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.49% |
-5.46% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.27% |
33.75% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
7.45% |
-6.37% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.57% |
0.26% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-3.77% |
6.89% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.85% |
3.03% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.38% |
14.88% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-4.13% |
2.99% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-4.14% |
2.84% |
2024-09-05 |
The percentage of cash held in the portfolio is:
48.87%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CDMO |
Buy
All
|
0.85% |
CARA |
Sell
All
|
-18.08% |
Assets Rebalanced
None
2024-09-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
6.01% |
0.21% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.42% |
-9.62% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.62% |
-6.22% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.57% |
3.43% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.71% |
7.2% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
8.79% |
-1.71% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.31% |
-7.1% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.24% |
33.96% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
7.28% |
-7.98% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.57% |
0.63% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.36% |
15.41% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.74% |
7.17% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.84% |
2.83% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.46% |
12.41% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-3.71% |
12.56% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-4.06% |
4.27% |
2024-09-05 |
The percentage of cash held in the portfolio is:
47.66%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BGNE |
Buy
All
|
-0.8% |
PACB |
Buy
All
|
-22.96% |
ALDX |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-09-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
6.3% |
3% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.75% |
-6.12% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.54% |
-9.51% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.78% |
4.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.71% |
5.05% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
8.46% |
-7.41% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.23% |
-9.84% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
8.05% |
14.37% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
7.86% |
-3.01% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
7.56% |
-6.48% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.68% |
0% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.39% |
16.54% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.95% |
3.86% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.99% |
1.1% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.54% |
12.41% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-4.73% |
-17.04% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-2.25% |
0.24% |
2024-09-02 |
VREX
Varex Imaging Corporation
|
Sell |
-4.27% |
1.28% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-4.14% |
4.27% |
2024-09-05 |
The percentage of cash held in the portfolio is:
48.34%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ORGO |
Sell
All
|
-12.72% |
Assets Rebalanced
None
2024-09-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.99% |
-1.42% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.67% |
-6.71% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.69% |
-6.41% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.56% |
-8.59% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.63% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.71% |
5.72% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
8.74% |
-3.7% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.53% |
-6.01% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.23% |
3.44% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
8.05% |
0% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
8.03% |
0% |
2024-09-06 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.43% |
14.93% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.94% |
3.61% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.97% |
1.07% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.79% |
5.44% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-4.16% |
-3.7% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-2.24% |
0.1% |
2024-09-02 |
VREX
Varex Imaging Corporation
|
Sell |
-4.4% |
-2.31% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-4.24% |
1.42% |
2024-09-05 |
The percentage of cash held in the portfolio is:
50.33%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.76% |
-5.21% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.79% |
-4.59% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.7% |
-6.12% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.38% |
-11.33% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.62% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.54% |
3.96% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
8.57% |
-5.41% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.01% |
-0.55% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.31% |
4.69% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
8.04% |
0% |
2024-09-05 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.52% |
12.67% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.97% |
2.72% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.98% |
0.61% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.83% |
4.42% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-3.92% |
2.22% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-2.2% |
1.63% |
2024-09-02 |
VREX
Varex Imaging Corporation
|
Sell |
-4.29% |
0% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-4.29% |
0% |
2024-09-05 |
The percentage of cash held in the portfolio is:
58.28%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CERS |
Sell
All
|
-11.34% |
EGRX |
Sell
All
|
-11.35% |
Assets Rebalanced
None
2024-09-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.93% |
-2.65% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.87% |
-3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.88% |
-3.5% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.51% |
-9.51% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
5.94% |
-7.98% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.41% |
-0.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.3% |
1.11% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
8.24% |
-10.38% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
8.49% |
-6.55% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.08% |
0% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7% |
0% |
2024-09-04 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.71% |
8.03% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-4.08% |
0.15% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.95% |
1.75% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.73% |
7.14% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-3.99% |
0.74% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-2.2% |
1.84% |
2024-09-02 |
The percentage of cash held in the portfolio is:
44.01%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
PINC |
Buy
All
|
-4.4% |
VERU |
Buy
All
|
-12.35% |
ARDX |
Sell
All
|
-11.62% |
NEOG |
Sell
All
|
-6.34% |
Assets Rebalanced
None
2024-09-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.72% |
-2.98% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.75% |
-2.4% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6% |
1.77% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.19% |
4.96% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.55% |
-5.85% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
5.93% |
-5.04% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.46% |
3.43% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
7.2% |
0.35% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
8.83% |
-0.81% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
8.8% |
-1.15% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
8.79% |
0% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.79% |
0% |
2024-09-02 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.89% |
0.38% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-4.05% |
-2.22% |
2024-08-28 |
PINC
Premier, Inc.
|
Sell |
-4.08% |
-2.93% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.94% |
-1.4% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.98% |
-2.38% |
2024-08-29 |
VERU
Veru Inc.
|
Sell |
-3.94% |
-1.23% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-3.95% |
-1.48% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-2.17% |
0% |
2024-09-02 |
The percentage of cash held in the portfolio is:
45.97%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.67% |
-3.77% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.72% |
-2.85% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.03% |
2.47% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.04% |
2.62% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.37% |
-8.78% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
6% |
-3.78% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.24% |
0% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
7.14% |
-0.41% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
8.93% |
0.36% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
8.97% |
0.77% |
2024-08-29 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.82% |
2.08% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.93% |
0.71% |
2024-08-28 |
PINC
Premier, Inc.
|
Sell |
-4.04% |
-2.07% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.87% |
0.47% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.94% |
-1.53% |
2024-08-29 |
VERU
Veru Inc.
|
Sell |
-3.93% |
-1.23% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-3.91% |
-0.74% |
2024-08-29 |
The percentage of cash held in the portfolio is:
61.33%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
LXRX |
Buy
All
|
19.28% |
Assets Rebalanced
None
2024-08-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.69% |
-3.45% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.64% |
-4.2% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.1% |
3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.11% |
3.79% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.5% |
-6.58% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
5.87% |
-5.88% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
5.99% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
7.01% |
-2.15% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
8.9% |
0% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
8.9% |
0% |
2024-08-29 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-2.82% |
22.87% |
2024-07-31 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.77% |
3.4% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.9% |
1.42% |
2024-08-28 |
PINC
Premier, Inc.
|
Sell |
-3.97% |
-0.3% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.88% |
0% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.88% |
0% |
2024-08-29 |
VERU
Veru Inc.
|
Sell |
-3.88% |
0% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-3.88% |
0% |
2024-08-29 |
The percentage of cash held in the portfolio is:
64.28%
New Assets Added
- LMAT
- AVXL
- VERU
- PACB
- PODD
- EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.68% |
-2.35% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.78% |
-0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.05% |
3.89% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.09% |
4.66% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.99% |
2.93% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
6.01% |
-2.52% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
5.92% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
7.08% |
0% |
2024-08-28 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-2.78% |
22.87% |
2024-07-31 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.75% |
2.74% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.91% |
0% |
2024-08-28 |
PINC
Premier, Inc.
|
Sell |
-3.91% |
0% |
2024-08-28 |
The percentage of cash held in the portfolio is:
65.75%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CYH |
Sell
All
|
4.72% |
Assets Rebalanced
None
2024-08-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
7.5% |
6.09% |
2024-07-29 |
ARDX
Ardelyx, Inc.
|
Buy |
5.7% |
-0.94% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.75% |
-0.05% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.16% |
7.07% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.21% |
7.87% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
6.18% |
7.31% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
6.1% |
0% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.1% |
0% |
2024-08-27 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-2.83% |
20.63% |
2024-07-31 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.74% |
2.08% |
2024-08-26 |
The percentage of cash held in the portfolio is:
56.87%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
7.12% |
-0.59% |
2024-07-29 |
ARDX
Ardelyx, Inc.
|
Buy |
5.81% |
-0.31% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.86% |
0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.03% |
3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.91% |
1.46% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
6.18% |
6.03% |
2024-08-23 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-2.97% |
17.94% |
2024-07-31 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.86% |
0% |
2024-08-26 |
The percentage of cash held in the portfolio is:
69.92%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
6.96% |
-4.32% |
2024-07-29 |
ARDX
Ardelyx, Inc.
|
Buy |
5.62% |
-5.02% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.81% |
-1.79% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.75% |
-2.83% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.91% |
0% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.91% |
0% |
2024-08-23 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-3.01% |
17.94% |
2024-07-31 |
The percentage of cash held in the portfolio is:
67.06%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
7.02% |
-2.95% |
2024-07-29 |
ARDX
Ardelyx, Inc.
|
Buy |
5.88% |
0% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.88% |
0% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.88% |
0% |
2024-08-22 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-3.12% |
14.35% |
2024-07-31 |
The percentage of cash held in the portfolio is:
78.46%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
7.08% |
-1.57% |
2024-07-29 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-2.7% |
25.56% |
2024-07-31 |
The percentage of cash held in the portfolio is:
95.62%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
EGRX |
Buy
All
|
4.43% |
NKTR |
Buy
All
|
7.41% |
RCM |
Sell
All
|
7.37% |
Assets Rebalanced
None